We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+13.49%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.34B
AUM Growth
-$346M
Cap. Flow
-$728M
Cap. Flow %
-21.78%
Top 10 Hldgs %
68.3%
Holding
475
New
106
Increased
41
Reduced
44
Closed
201

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$447M
2
CYBR
CyberArk
CYBR
+$424M
3
GTLS
Chart Industries
GTLS
+$243M
4
IPG
Interpublic Group of Companies
IPG
+$96.3M
5
COOP
Mr. Cooper
COOP
+$67.2M

Top Sells

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$288M
2
SKX
Skechers
SKX
+$227M
3
BPMC
Blueprint Medicines
BPMC
+$220M
4
CHX
ChampionX
CHX
+$187M
5
ANSS
Ansys
ANSS
+$173M

Sector Composition

Rank Sector Weight
1 Technology 21.6%
2 Industrials 16.01%
3 Healthcare 15.52%
4 Communication Services 12.09%
5 Financials 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARCO icon
76
Arcos Dorados Holdings
ARCO
$1.74B
$3.62M 0.11%
536,643
-124,429
-19% -$883K
FLR icon
77
Fluor
FLR
$7.69B
$3.53M 0.11%
+83,890
New +$3.86M
NCLH icon
78
Norwegian Cruise Line
NCLH
$7.16B
$3.33M 0.1%
135,000
– –
LOKV
79
DELISTED
Live Oak Acquisition Corp V
LOKV
$3.31M 0.1%
324,923
+150,000
+86% +$1.54M
VRT icon
80
Vertiv
VRT
$103B
$3.23M 0.1%
+21,400
New +$2.85M
BSAC icon
81
Banco Santander Chile
BSAC
$16.9B
$3.17M 0.1%
119,793
– –
ZK
82
DELISTED
Zeekr
ZK
$3.17M 0.09%
104,037
+64,937
+166% +$1.88M
OACC
83
Oaktree Acquisition Corp III Life Sciences
OACC
$265M
$3.15M 0.09%
300,000
+100,000
+50% +$1.04M
ACMR icon
84
ACM Research
ACMR
$4.84B
$3.11M 0.09%
79,396
-12,725
-14% -$378K
VIST icon
85
Vista Energy
VIST
$8.25B
$3.07M 0.09%
89,299
+57,908
+184% +$2.4M
BBAR icon
86
BBVA Argentina
BBAR
$3.08B
$3.07M 0.09%
368,434
+175,944
+91% +$2.38M
CEPF
87
Cantor Equity Partners IV
CEPF
$594M
$3.06M 0.09%
+300,000
New +$3.05M
TVA
88
Texas Ventures Acquisition III Corp
TVA
$317M
$2.95M 0.09%
275,466
-124,534
-31% -$1.27M
TOST icon
89
Toast
TOST
$19.6B
$2.92M 0.09%
+80,000
New +$3.47M
GLOB icon
90
Globant
GLOB
$1.74B
$2.91M 0.09%
50,726
+14,799
+41% +$1.09M
TSEM icon
91
Tower Semiconductor
TSEM
$23.3B
$2.82M 0.08%
+39,044
New +$2.13M
ULTA icon
92
Ulta Beauty
ULTA
$23.8B
$2.73M 0.08%
5,000
-8,217
-62% -$4.21M
ACEL icon
93
Accel Entertainment
ACEL
$958M
$2.73M 0.08%
246,728
– –
SRAD icon
94
Sportradar
SRAD
$3.88B
$2.69M 0.08%
+100,000
New +$2.97M
AAM
95
DELISTED
AA Mission Acquisition Corp
AAM
$2.63M 0.08%
+250,000
New +$2.62M
CRC icon
96
California Resources
CRC
$4.74B
$2.63M 0.08%
+49,400
New +$2.48M
AVGO icon
97
Broadcom
AVGO
$1.7T
$2.62M 0.08%
7,950
-18,854
-70% -$5.78M
NETD
98
DELISTED
Nabors Energy Transition Corp II
NETD
$2.62M 0.08%
233,912
– –
CCIX
99
DELISTED
Churchill Capital Corp IX
CCIX
$2.62M 0.08%
250,000
– –
MLAC
100
DELISTED
Mountain Lake Acquisition Corp
MLAC
$2.58M 0.08%
250,000
– –
2 3
4
5 6

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2025 Portfolio in Review

As of Q3 2025, UBS O'Connor held 475 positions worth $3.34B, down 9.4% from $3.69B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

UBS O'Connor withdrew a net $728M in Q3 2025, closing 201 positions and reducing 44 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $288M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Verona Pharma worth $457M.

  • UBS O'Connor's largest Q3 2025 buy was Verona Pharma: 4,283,462 shares worth $457M.
  • UBS O'Connor added most to Interpublic Group of Companies in Q3 2025, an estimated $96.3M increase.
  • UBS O'Connor's biggest Q3 2025 reduction was Kellanova, cutting an estimated $110M.
  • UBS O'Connor fully exited Walgreens Boots Alliance in Q3 2025, selling an estimated $288M.
  • UBS O'Connor's ten largest holdings make up 68% of its $3.34B portfolio in Q3 2025.
  • UBS O'Connor opened 106 new positions and closed 201 in Q3 2025.
  • UBS O'Connor's portfolio value fell 9.4% quarter-over-quarter to $3.34B.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.